Ekbom syndrome: A disease between dermatology and psychiatry

Giornale Italiano di Dermatologia e Venereologia

Volumn 143, Issue 6, 2008, Pages 415-419

  Simonetti, V ^a   Strippoli, D ^a   Pinciara, B ^a   Spreafico, A ^a   Motolese, A ^b  

^a A MANZONI HOSPITAL   (Italy)

^b OSPEDALE DI CIRCOLO   (Italy)

Author keywords

Parasitic diseases Psychotic disorders Delirium

Indexed keywords

ANTIINFECTIVE AGENT; DIAZEPAM; HYDROXYZINE; QUETIAPINE; STEROID; UNCLASSIFIED DRUG; VIOFORM OXIDE; VIOMYCIN;

ADULT; ANXIETY DISORDER; ARTICLE; CASE REPORT; DELIRIUM; DEPRESSION; DRUG DOSE INCREASE; EKBOM SYNDROME; FEMALE; HUMAN; HYPOCHONDRIASIS; PARASITOSIS; PSYCHOSIS; SKIN INFECTION; SKIN INJURY; SYNDROME;

EID: 59749083967     PISSN: 03920488     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (20)

1. Driscoll MS, Rothe MJ, Grant-Kels JM, Hale MS. Delusional parasitosis: a dermatologic, psychiatric, and pharmacologic approach. J Am Acad Dermatol 1993;29:1023-33.
2. Madoz-Gurpide A, Garcia Resa E. Delusional parasitosis. Med Clin 2004;123:66-9.
3. Medansky RS, Handler RM. Dermatopsychosomatic: classification, physiology, and therapeutic approaches. J Am Acad Dermatol 1981;5:125-36.
4. Bhatia MS, Jagawat T, Choudhary S. Delusional parasitosis: a clinical profile. Int J Psychiatry Med 2000;30:83-91.
5. American Psychiatric Association Committee on Nomenclature and Statistics. Diagnostic and statistical manual of mental disorders, 4th edition (DSMIV) Washington DC: APA, 1994.
6. Panconesi P. Psychosomatic dermatology. Clin Dermatol 1984;2:94-179.
7. Gupta MA, Gupta AK. Psychodermatology: An update. J Am Acad Dermatol 1996;34:1030-46.
8. Thibièrge G. Acarophobes di Les. Rev Gen Clin Ther 1894;32:373-6.
9. Ekbom KA. Derprasenile dermatozoenwahn. Aus Derm Krakenhause Beckomerba 1938;13:227-59.
10. Folks DG, Kinney FC. The role of psychological factors in dermatologic conditions. Psychosomatics 1992;33:45-54.
11. Kim C, Kim J, Lee M, Kang M. Delusional parasitosis as «folie à deux». J Korean Med Sci 2003;18:462-5.
12. Koo JYM, Pham CT. Psychodermatology: Practical guidelines on pharmacotherapy. Arch Dermatol 1992;126:381-8.
13. Ait-Ameur A, Bern P, Firoloni MP, Menecier P. Delusional parasitosis or Ekbom's Syndrome. Rev Med Interne 2000;21:182-6.
14. Hummer M, Fleischhacker WW. Copliance and out come in patients treated with antipsychotics: the impact of extrapyramidal sindrome. CNS Drugs 1996;5:13-20
15. Leslie DL, Rosenheck RA. From conventional to atipical antipsychotics and back: dynamic processes in the diffusion of new medications. Am J Psychiatry 2002;159:1534-40.
16. Seeman P. Atypical antipsychotics: mechanism of action. Can J Psychiatry 2002;47:27-38.
17. Gardner DM, Baldessarini RJ, Waraich P. Modern antipsychotic drugs: a critical overview. CMAJ 2005;172:1703-11
18. Schwartz TL, Masand PS. The role of atypical antipsychotics in the treatment of delirium. Psychosomatics 2002;43:171-4.
19. Goldstein GM. Quetiapine fumarate (Seroquel): a new atypical antipsychotic. Drugs Today 1999;35:193-210.
20. Weiden PJ. Switching antipsychotics: an updated review with a focus an quetiapine. J Psychopharmacol 2006;20:104-18.